文献速递前列腺癌

前列腺癌患者根治性前列腺切除标本中正常与肿瘤区域胆固醇代谢的个体化比较:CHOMECAP研究结果

Individual Comparison of Cholesterol Metabolism in Normal and Tumour Areas in Radical Prostatectomy Specimens from Patients with Prostate Cancer: Results of the CHOMECAP Study.
PubMed 文献 · Eur Urol Oncol · 2018-08-24

CHOMECAP研究对69例局限性前列腺癌患者根治性前列腺切除标本中的配对正常与肿瘤组织进行基因分析、固醇测定和免疫组化比较。结果显示肿瘤组织从头胆固醇合成显著下调、SCARB1过表达54.7%、ACAT1显著降低、APOE外排改变,且7αOHC、7βOHC和7-酮固醇积累更高、27OHC更低,总体胆固醇浓度无显著差异。

要点

  • 肿瘤组织从头胆固醇合成显著下调,SCARB1过表达54.7%可增加高密度脂蛋白摄取。
  • 肿瘤组织ACAT1显著降低、APOE外排改变,7αOHC、7βOHC和7-酮固醇积累更高、27OHC更低。
  • 配对组织总体胆固醇浓度无显著差异,但肿瘤呈现特定代谢通量偏移特征。

核心结论

  • 基于个体配对前列腺组织,研究揭示正常与肿瘤样本间存在与胆固醇通量代谢偏移相关的多项差异。
  • 前列腺癌样本呈现SCARB1表达更高、OHC类物质积累更高和从头胆固醇合成明显下调的特定组织特征。

研究设计与样本

  • 2008年至2012年间,从69例接受根治性前列腺切除的局限性前列腺癌患者标本中采集配对正常与肿瘤组织。
  • 肿瘤与正常组织接受基因分析、固醇测定和免疫组化;采用Wilcoxon配对检验和Spearman检验分别进行比较与相关分析,并进行主成分分析。

主要发现

  • 总体胆固醇浓度在组织配对间无显著差异。
  • 肿瘤样本与从头胆固醇合成显著下调相关,但SCARB1过表达54.7%,可能增加前列腺癌中高密度脂蛋白摄取。
  • 肿瘤组织显示可用胆固醇转运不同,ACAT1显著降低,并经APOE外排改变。
  • 肿瘤组织胆固醇代谢以7αOHC、7βOHC和7-酮固醇积累更高、27OHC水平更低为特征。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deregulation of cholesterol metabolism represents a hallmark of prostate cancer (PCa) and promotes its development. OBJECTIVE: To compare cholesterol metabolism on individual paired normal and tumour prostate tissues obtained from patients with PCa. DESIGN, SETTING, AND PARTICIPANTS: Between 2008 and 2012, normal and tumour paired tissue samples were collected from radical prostatectomy specimens from a cohort of 69 patients treated for localised PCa. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Tumour and normal tissues were subjected to gene analysis, sterol measurement, and immunohistochemistry. The Wilcoxon paired test and Spearman test were applied for comparison and correlation analyses, respectively. Principal component analysis was also carried out to investigate relationships between quantitative variables. RESULTS AND LIMITATIONS: Overall, cholesterol concentrations were not significantly different between tissue pairs. However, tumour samples were significantly associated with downregulated de novo cholesterol synthesis, but exhibited 54.7% overexpression of SCARB1 that could increase high-density lipoprotein uptake in PCa. Tumour tissues showed different trafficking of available cholesterol, with significantly lower ACAT1, and an altered efflux via APOE. Furthermore, cholesterol metabolism in tumour tissues was characterised by higher accumulation of 7α-hydroxycholesterol (OHC), 7βOHC, and 7-ketosterol, and a lower level of 27OHC. CONCLUSIONS: Focusing on individually paired prostate tissues, our results highlighted several differences between normal and tumour samples linked to a metabolic shift in cholesterol flux. PCa samples exhibited a specific tissue signature characterised by higher SCARB1 expression, higher accumulation of OHC species, and clear downregulation of de novo cholesterol synthesis. PATIENT SUMMARY: Comparing normal and tumour tissues from the same prostates, our study identified a set of alterations in prostate cancer samples in terms of their use of cholesterol. These included higher cholesterol uptake, accumulation of oxidised cholesterol derivatives, and autonomous cellular production of cholesterol. Together, these data provide promising clinical targets to fight prostate cancer.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Celhay O, Bousset L, Guy L, et al. Individual Comparison of Cholesterol Metabolism in Normal and Tumour Areas in Radical Prostatectomy Specimens from Patients with Prostate Cancer: Results of the CHOMECAP Study. Eur Urol Oncol. 2018. PMID: 31017097. doi:10.1016/j.euo.2018.08.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。